USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	057715/0788			Pages:	28
		Recorded:	09/20/2021
Attorney Dkt #:	ZSP BIONTECH MERGER LIST
Conveyance:	MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 11

Patent #:	11045418	Issue Dt:	06/29/2021	Application #:	15554132	Filing Dt:	08/28/2017
Publication #:	US20180263907	Pub Dt:	09/20/2018
Title:	Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell

Patent #:	11168337	Issue Dt:	11/09/2021	Application #:	16086157	Filing Dt:	09/18/2018
Publication #:	US20200299725	Pub Dt:	09/24/2020
Title:	RNA Replicon for Versatile and Efficient Gene Expression

Patent #:	NONE	Issue Dt:		Application #:	16091389	Filing Dt:	10/04/2018
Publication #:	US20190153425	Pub Dt:	05/23/2019
Title:	Methods for Providing Single-Stranded RNA

Patent #:	10808019	Issue Dt:	10/20/2020	Application #:	16374503	Filing Dt:	04/03/2019
Publication #:	US20190276511	Pub Dt:	09/12/2019
Title:	Nucleic Acid Molecules Encoding Cytokine Fusion Proteins Comprising Tumor Necrosis Factor (TNF) Superfamily Ligands

Patent #:	NONE	Issue Dt:		Application #:	16645707	Filing Dt:	03/09/2020
Publication #:	US20200277627	Pub Dt:	09/03/2020
Title:	RNA REPLICON FOR REPROGRAMMING SOMATIC CELLS

Patent #:	NONE	Issue Dt:		Application #:	17262180	Filing Dt:	01/21/2021
Publication #:	US20210290746	Pub Dt:	09/23/2021
Title:	Individualized Vaccines for Cancer

Patent #:	NONE	Issue Dt:		Application #:	17281697	Filing Dt:	03/31/2021
Publication #:	US20220001025	Pub Dt:	01/06/2022
Title:	RNA Particles Comprising Polysarcosine

Patent #:	11337922	Issue Dt:	05/24/2022	Application #:	17330342	Filing Dt:	05/25/2021
Publication #:	US20210338580	Pub Dt:	11/04/2021
Title:	Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell

Assignor

Exec Dt:

06/22/2021

Newly Merged Entity Data

Exec Dt:

06/22/2021

Newly Merged Entity's New Name

AN DER GOLDGRUBE 12

MAINZ, GERMANY 55131

Correspondence name and address
	MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
	300 SOUTH WACKER DRIVE
	CHICAGO, IL 60606

Search Results as of: 06/17/2024 09:05 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6